SARS-CoV-2 whole-genome sequencing using reverse complement PCR: For easy, fast and accurate outbreak and variant analysis.
COVID-19
Lineage
Mutation
RC-PCR
SARS-CoV-2
WGS
Journal
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology
ISSN: 1873-5967
Titre abrégé: J Clin Virol
Pays: Netherlands
ID NLM: 9815671
Informations de publication
Date de publication:
11 2021
11 2021
Historique:
received:
02
03
2021
revised:
21
09
2021
accepted:
29
09
2021
pubmed:
8
10
2021
medline:
3
11
2021
entrez:
7
10
2021
Statut:
ppublish
Résumé
During the course of the SARS-CoV-2 pandemic reports of mutations with effects on spreading and vaccine effectiveness emerged. Large scale mutation analysis using rapid SARS-CoV-2 Whole Genome Sequencing (WGS) is often unavailable but could support public health organizations and hospitals in monitoring transmission and rising levels of mutant strains. Here we report a novel WGS technique for SARS-CoV-2, the EasySeq™ RC-PCR SARS-CoV-2 WGS kit. By applying a reverse complement polymerase chain reaction (RC-PCR), an Illumina library preparation is obtained in a single PCR, thereby saving time, resources and facilitating high-throughput screening. Using this WGS technique, we evaluated SARS-CoV-2 diversity and possible transmission within a group of 173 patients and healthcare workers (HCW) of the Radboud university medical center during 2020. Due to the emergence of variants of concern, we screened SARS-CoV-2 positive samples in 2021 for identification of mutations and lineages. With use of EasySeq™ RC-PCR SARS-CoV-2 WGS kit we were able to obtain reliable results to confirm outbreak clusters and additionally identify new previously unassociated links in a considerably easier workaround compared to current methods. Furthermore, various SARS-CoV-2 variants of interest were detected among samples and validated against an Oxford Nanopore sequencing amplicon strategy which illustrates this technique is suitable for surveillance and monitoring current circulating variants.
Identifiants
pubmed: 34619382
pii: S1386-6532(21)00260-2
doi: 10.1016/j.jcv.2021.104993
pmc: PMC8487099
pii:
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
104993Informations de copyright
Copyright © 2021. Published by Elsevier B.V.
Références
Sci Rep. 2017 May 8;7(1):1567
pubmed: 28484262
Nat Commun. 2020 Jul 8;11(1):3496
pubmed: 32641684
J Infect. 2021 May;82(5):e23-e24
pubmed: 33548358
Bioinformatics. 2018 Sep 1;34(17):i884-i890
pubmed: 30423086
J Med Virol. 2020 Jun;92(6):667-674
pubmed: 32167180
Lancet Infect Dis. 2020 May;20(5):533-534
pubmed: 32087114
Cell. 2021 Mar 4;184(5):1171-1187.e20
pubmed: 33621484
Fly (Austin). 2012 Apr-Jun;6(2):80-92
pubmed: 22728672
Mol Biol Evol. 2020 May 1;37(5):1530-1534
pubmed: 32011700
Euro Surveill. 2020 Apr;25(13):
pubmed: 32265007
Lancet Infect Dis. 2020 Nov;20(11):1273-1280
pubmed: 32622380
Cell Rep Med. 2020 Sep 22;1(6):100098
pubmed: 32904687
BMC Bioinformatics. 2018 Aug 29;19(1):307
pubmed: 30157759
Emerg Microbes Infect. 2020 Dec;9(1):1457-1466
pubmed: 32543353
N Engl J Med. 2020 Jun 11;382(24):2302-2315
pubmed: 32289214
Lancet Microbe. 2020 Jul;1(3):e99-e100
pubmed: 32835336
Nucleic Acids Res. 2016 Jul 8;44(W1):W160-5
pubmed: 27079975
Euro Surveill. 2020 Jan;25(3):
pubmed: 31992387
N Engl J Med. 2020 Feb 20;382(8):727-733
pubmed: 31978945
Genome Med. 2021 Feb 9;13(1):21
pubmed: 33563320
Bioinformatics. 2017 May 15;33(10):1505-1513
pubmed: 28172447
Biol Methods Protoc. 2020 Jul 18;5(1):bpaa014
pubmed: 33029559
Microbiol Resour Announc. 2021 Jan 7;10(1):
pubmed: 33414350
Nat Med. 2020 Sep;26(9):1405-1410
pubmed: 32678356
Genes (Basel). 2020 Aug 17;11(8):
pubmed: 32824573
Nat Protoc. 2017 Jun;12(6):1261-1276
pubmed: 28538739
Lancet Infect Dis. 2020 Nov;20(11):1263-1272
pubmed: 32679081
PLoS One. 2020 Sep 18;15(9):e0239403
pubmed: 32946527
Nat Microbiol. 2020 Nov;5(11):1403-1407
pubmed: 32669681
Bioinformatics. 2010 Aug 1;26(15):1899-900
pubmed: 20427515